In the last 12 months, insiders at Telix Pharmaceuticals Ltd ($TLX) filed 4 transactions with the SEC: 2 open-market purchases totaling $996,738 and 0 sales totaling $0. Net insider sentiment: net buying.
Telix Pharmaceuticals Ltd operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Behrenbruch Christian (MD & Group CEO) — 2 transactions totaling $996,738
- Smith Darren Charlton (Group Chief Financial Officer) — 2 transactions totaling $0
View all SEC Filings for Telix Pharmaceuticals Ltd (TLX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 28, 2026 | Behrenbruch Christian | MD & Group CEO | P | Ordinary Shares | 34500 | $14.48 | 20,709,500.0000 | 338,777,049 | 0.17% | 0.01% |
| April 29, 2026 | Behrenbruch Christian | MD & Group CEO | P | Ordinary Shares | 33435 | $14.87 | 20,742,935.0000 | 338,777,049 | 0.16% | 0.01% |
| March 29, 2026 | Smith Darren Charlton | Group Chief Financial Officer | M | Ordinary Shares | 1111 | $0.00 | 11,921.0000 | 338,777,049 | 10.28% | 0.00% |
| March 29, 2026 | Smith Darren Charlton | Group Chief Financial Officer | M | Share Rights | 1111 | $0.00 | 0.0000 | 338,777,049 | 100.00% | 0.00% |